Clinical trial
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With…
NCT00276861 · University of Miami, Other · Terminated
Key facts
| NCT number | NCT00276861 |
|---|---|
| Title | Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer |
| Official title | Phase II Study of Oxaliplatin And Fixed Rate Infusion Gemcitabine as Second Line Therapy for Patients With Metastatic Colon Cancer |
| Lead sponsor | University of Miami, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, oxaliplatin |
| Enrollment | 10 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | May 1, 2008 |
| First posted | Jan 13, 2006 |
| Last update posted | Feb 8, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: